Effect of nonpayment for preventable infections in U.S. Hospitals

New England Journal of Medicine

Volumn 367, Issue 15, 2012, Pages 1428-1437

  Lee, Grace M ^a,b   Kleinman, Ken ^a   Soumerai, Stephen B ^a   Tse, Alison ^a   Cole, David ^a   Fridkin, Scott K ^d   Horan, Teresa ^d   Platt, Richard ^a   Gay, Charlene ^a   Kassler, William ^c   Goldmann, Donald A ^c   Jernigan, John ^d   Jha, Ashish K ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOODSTREAM INFECTION; CONTROLLED STUDY; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH INSURANCE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RATE; MANDATORY REPORTING; MEDICAID; MEDICARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; TIME SERIES ANALYSIS; TREND STUDY; UNITED STATES; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84867226630     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsa1202419     Document Type: Article

References (55)

1. Rosenthal MB, Landon BE, Normand SL, Frank RG, Epstein AM. Pay for performance in commercial HMOs. N Engl J Med 2006;355:1895-902.
2. Scott A, Sivey P, Ait Ouakrim D, et al. The effect of financial incentives on the quality of health care provided by primary care physicians. Cochrane Database Syst Rev 2011;9:CD008451.
3. Van Herck P, De Smedt D, Annemans L, Remmen R, Rosenthal MB, Sermeus W. Systematic review: effects, design choices, and context of pay-for-performance in health care. BMC Health Serv Res 2010;10:247.
4. Glickman SW, Ou FS, DeLong ER, et al. Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA 2007;297:2373-80.
5. Lindenauer PK, Remus D, Roman S, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med 2007;356:486-96.
6. Werner RM, Bradlow ET. Relationship between Medicare's Hospital Compare performance measures and mortality rates. JAMA 2006;296:2694-702. [Erratum, JAMA 2007;297:700.]
7. Ryan AM. Effects of the Premier Hospital Quality Incentive Demonstration on Medicare patient mortality and cost. Health Serv Res 2009;44:821-42.
8. Werner RM, Kolstad JT, Stuart EA, Polsky D. The effect of pay-for-performance in hospitals: lessons for quality improvement. Health Aff (Millwood) 2011;30:690-8.
9. Hospital-acquired conditions (present on admission indicator): overview. Baltimore: Centers for Medicare & Medicaid Services, 2011 (http://www.cms.gov/HospitalAcqCond/01-Overview.asp).
10. Rosenthal MB. Nonpayment for performance? Medicare's new reimbursement rule. N Engl J Med 2007;357:1573-5.
11. Idem. Beyond pay for performance - emerging models of provider-payment reform. N Engl J Med 2008;359:1197-200.
12. Wald HL, Kramer AM. Nonpayment for harms resulting from medical care: catheter-associated urinary tract infections. JAMA 2007;298:2782-4.
13. Saint S, Meddings JA, Calfee D, Kowal ski CP, Krein SL. Catheter-associated urinary tract infection and the Medicare rule changes. Ann Intern Med 2009;150:877-84.
14. Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science 1981;211:453-8.
15. McClellan M. Moving toward accountable care. Washington, DC: The Brookings Institution, 2009 (http://www.ehcca.com/presentations/ healthpolicyaudio20090521/mcclellan.pdf).
16. Centers for Medicare and Medicaid Services. Medicaid program: payment adjustment for provider-preventable conditions including health care-acquired conditions. Fed Regist 2011;76:32816 (http://www.gpo.gov/fdsys/pkg/FR-2011-06- 06/pdf/2011-13819.pdf).
17. American Hospital Association. Medicaid non-payment for healthcare associated conditions: final rule. June 23, 2011 (http://www.scha.org/files/ documents/aha-summary-of-medicaid-nonpayment-for-hacs.pdf).
18. McNutt R, Johnson TJ, Odwazny R, et al. Change in MS-DRG assignment and hospital reimbursement as a result of Centers for Medicare & Medicaid changes in payment for hospital-acquired conditions: is it coding or quality? Qual Manag Health Care 2010;19:17-24.
19. Teufack SG, Campbell P, Jabbour P, Maltenfort M, Evans J, Ratliff JK. Potential financial impact of restriction in "never event" and periprocedural hospital-acquired condition reimbursement at a tertiary neurosurgical center: a single-institution prospective study. J Neurosurg 2010;112:249-56.
20. Meddings J, Saint S, McMahon LF Jr. Hospital-acquired catheter-associated urinary tract infection: documentation and coding issues may reduce financial impact of Medicare's new payment policy. Infect Control Hosp Epidemiol 2010;31:627-33.
21. Zhan C, Elixhauser A, Richards CL Jr, et al. Identification of hospital-acquired catheter-associated urinary tract infections from Medicare claims: sensitivity and positive predictive value. Med Care 2009;47:364-9.
22. McNair PD, Luft HS, Bindman AB. Medicare's policy not to pay for treating hospital-acquired conditions: the impact. Health Aff (Millwood) 2009;28:1485-93.
23. National Healthcare Safety Network (NHSN). Atlanta: Centers for Disease Control and Prevention (http://www.cdc.gov/nhsn/).
24. Dudeck MA, Horan TC, Peterson KD, et al. National Healthcare Safety Network (NHSN) Report, data summary for 2010, device-associated module. Am J Infect Control 2011;39:798-816.
25. American Hospital Association annual survey database fiscal year 2009. Chicago: Health Forum LLC, 2010.
26. Methicillin-resistant Staphylococcus aureus (MRSA) and other healthcare-associated infections. Washington, DC: National Conference of State Legislatures (http://www.ncsl.org/default.aspx?tabid=14084).
27. State-based HAI prevention. Atlanta: Centers for Disease Control and Prevention (http://www.cdc.gov/HAI/state-based/index.html).
28. Association for Professionals in Infection Control and Epidemiology (APIC) home page (http://www.apic.org/).
29. Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experimental designs for generalized causal inference. Boston: Houghton-Mifflin, 2002.
30. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32. [Erratum, Am J Infect Control 2008;36:655.]
31. Stevenson KB, Khan Y, Dickman J, et al. Administrative coding data, compared with CDC/NHSN criteria, are poor indicators of health care-associated infections. Am J Infect Control 2008;36:155-64.
32. Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA 2009;301:727-36.
33. Burton DC, Edwards JR, Srinivasan A, Fridkin SK, Gould CV. Trends in catheter-associated urinary tract infections in adult intensive care units - United States, 1990-2007. Infect Control Hosp Epidemiol 2011;32:748-56.
34. Hartmann CW, Hoff T, Palmer JA, Wroe P, Dutta-Linn MM, Lee G. The Medicare policy of payment adjustment for health care-associated infections: perspectives on potential unintended consequences. Med Care Res Rev 2012;69:45-61.
35. McHugh M, Van Dyke K, Osei-Anto A, Haque A. Medicare's payment policy for hospital-acquired conditions: perspectives of administrators from safety net hospitals. Med Care Res Rev 2011;68:667-82.
36. Healthcare-associated infections. Rock ville, MD: Agency for Healthcare Research and Quality (http://www.ahrq.gov/qual/hais.htm).
37. The Society for Healthcare Epidemiology of America home page (http://www.shea-online.org).
38. Reduce healthcare-associated infections. Cambridge, MA: Institute for Healthcare Improvement (http://www.ihi.org/explore/HAI/Pages/default.aspx).
39. Healthcare-associated infections (HAI). Washington, DC: National Quality Forum (http://www.qualityforum.org/Projects/h/Healthcare-Associated-Infections- (HAI)/Healthcare-Associated-Infections-(HAI).aspx).
40. The Joint Commission. Infection control (http://www.jointcommission.org/ infection-control.aspx).
41. Hoff T, Hartmann CW, Soerensen C, Wroe P, Dutta-Linn M, Lee G. Making the CMS payment policy for healthcare-associated infections work: organizational factors that matter. J Healthc Manag 2011;56:319-35.
42. Sherman ER, Heydon KH, St John KH, et al. Administrative data fail to accurately identify cases of healthcare-associated infection. Infect Control Hosp Epidemiol 2006;27:332-7.
43. Zrelak PA, Sadeghi B, Utter GH, et al. Positive predictive value of the Agency for Healthcare Research and Quality Patient Safety Indicator for central line-related bloodstream infection ("selected infections due to medical care"). J Healthc Qual 2011;33:29-36.
44. Serumaga B, Ross-Degnan D, Avery AJ, et al. Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study. BMJ 2011;342:d108.
45. Ryan AM, Blustein J. The effect of the MassHealth hospital pay-for-performance program on quality. Health Serv Res 2011;46:712-28.
46. Jha AK, Joynt KE, Orav EJ, Epstein AM. The long-term effect of premier pay for performance on patient outcomes. N Engl J Med 2012;366:1606-15.
47. Emmert M, Eijkenaar F, Kemter H, Esslinger AS, Schoffski O. Economic evaluation of pay-for-performance in health care: a systematic review. Eur J Health Econ 2011 June 10 (Epub ahead of print).
48. Karve AM, Ou FS, Lytle BL, Peterson ED. Potential unintended financial consequences of pay-for-performance on the quality of care for minority patients. Am Heart J 2008;155:571-6.
49. Werner RM, Goldman LE, Dudley RA. Comparison of change in quality of care between safety-net and non-safety-net hospitals. JAMA 2008;299:2180-7.
50. Werner RM, Asch DA, Polsky D. Racial profiling: the unintended consequences of coronary artery bypass graft report cards. Circulation 2005;111:1257-63.
51. Krein SL, Kowalski CP, Hofer TP, Saint S. Preventing hospital-acquired infections: a national survey of practices reported by U.S. hospitals in 2005 and 2009. J Gen Intern Med 2012;27:773-9.
52. Stone PW, Glied SA, McNair PD, et al. CMS changes in reimbursement for HAIs: setting a research agenda. Med Care 2010;48:433-9.
53. Lee GM, Hartmann CW, Graham D, et al. Perceived impact of the Medicare policy to adjust payment for health care-associated infections. Am J Infect Control 2012;40:314-9.
54. Stone PW, Pogorzelska M, Graham D, Jia H, Uchida M, Larson EL. California hospitals response to state and federal policies related to health care-associated infections. Policy Polit Nurs Pract 2011;12:73-81.
55. Department of Health and Human Services. Statement by Kathleen Sebelius, Secretary, Department of Health and Human Services, on Medicare's future: an examination of the Independent Payment Advisory Board. July 12, 2011 (http://www.hhs.gov/asl/testify/2011/07/t20110712c.html).